BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 23909968)

  • 1. Mirtazapine improves visual hallucinations in Parkinson's disease: a case report.
    Tagai K; Nagata T; Shinagawa S; Tsuno N; Ozone M; Nakayama K
    Psychogeriatrics; 2013 Jun; 13(2):103-7. PubMed ID: 23909968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hallucinations and psychosis in Parkinson's disease.
    Rabey JM
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 4():S105-10. PubMed ID: 20123547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease.
    Meco G; Bernardi S
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):311-3. PubMed ID: 16919377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. When a Parkinson's disease patient starts to hallucinate.
    Poewe W
    Pract Neurol; 2008 Aug; 8(4):238-41. PubMed ID: 18644910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hallucinations and the spectrum of psychosis in Parkinson's disease.
    Frei K; Truong DD
    J Neurol Sci; 2017 Mar; 374():56-62. PubMed ID: 28108020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case in which mirtazapine reduced auditory hallucinations in a patient with Parkinson disease.
    Nagata T; Shinagawa S; Tagai K; Nakayama K
    Int Psychogeriatr; 2013 Jul; 25(7):1199-201. PubMed ID: 23195073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of hallucinations and psychosis in Parkinson's disease.
    Eng ML; Welty TE
    Am J Geriatr Pharmacother; 2010 Aug; 8(4):316-30. PubMed ID: 20869621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Psychosis in Parkinson's disease].
    Rongve A; Auning E; Ehrt U; Arsland D
    Tidsskr Nor Laegeforen; 2012 Jan; 132(2):155-8. PubMed ID: 22278271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson's disease psychosis 2010: a review article.
    Friedman JH
    Parkinsonism Relat Disord; 2010 Nov; 16(9):553-60. PubMed ID: 20538500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychosis in nursing home patients with Parkinson's disease.
    Kang GA; Bronstein JM
    J Am Med Dir Assoc; 2004; 5(3):167-73. PubMed ID: 15115577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parenteral ziprasidone: a new atypical neuroleptic for emergency treatment of psychosis in Parkinson's disease?
    Oechsner M; Korchounov A
    Hum Psychopharmacol; 2005 Apr; 20(3):203-5. PubMed ID: 15799011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of parkinsonism and psychosis with mirtazapine: a case report.
    Godschalx-Dekker JA; Siegers HP
    Pharmacopsychiatry; 2014 May; 47(3):81-3. PubMed ID: 24504487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychosis in Parkinson's disease.
    Thanvi BR; Lo TC; Harsh DP
    Postgrad Med J; 2005 Oct; 81(960):644-6. PubMed ID: 16210460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of psychosis in Parkinson's disease.
    D'Souza C; Gupta A; Alldrick MD; Sastry BS
    Int J Clin Pract; 2003 May; 57(4):295-300. PubMed ID: 12800461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group.
    Ravina B; Marder K; Fernandez HH; Friedman JH; McDonald W; Murphy D; Aarsland D; Babcock D; Cummings J; Endicott J; Factor S; Galpern W; Lees A; Marsh L; Stacy M; Gwinn-Hardy K; Voon V; Goetz C
    Mov Disord; 2007 Jun; 22(8):1061-8. PubMed ID: 17266092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Parkinson's disease. Psychological disorders: striking a balance in order to optimise antiparkinsonian treatment.
    Prescrire Int; 2011 Oct; 20(120):242-5. PubMed ID: 21970092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Psychiatric complications of Parkinson's disease: their symptoms and treatment].
    Castro-GarcĂ­a A; Sesar-Ignacio A; Ares-Pensado B
    Rev Neurol; 2004 Oct 1-15; 39(7):646-50. PubMed ID: 15490352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychosis in Parkinson's disease.
    Wint DP; Okun MS; Fernandez HH
    J Geriatr Psychiatry Neurol; 2004 Sep; 17(3):127-36. PubMed ID: 15312276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New approaches to understanding hallucinations in Parkinson's disease: phenomenology and possible origins.
    Onofrj M; Thomas A; Bonanni L
    Expert Rev Neurother; 2007 Dec; 7(12):1731-50. PubMed ID: 18052766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pimavanserin: A Novel Antipsychotic for Parkinson's Disease Psychosis.
    Bozymski KM; Lowe DK; Pasternak KM; Gatesman TL; Crouse EL
    Ann Pharmacother; 2017 Jun; 51(6):479-487. PubMed ID: 28375643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.